XML 21 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Fair Value Measurements and Fair Value of Financial Instruments
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements and Fair Value of Financial Instruments FAIR VALUE MEASUREMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS
The following tables set forth the fair value of the Company’s financial assets that were measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands).
September 30, 2023
Level 1Level 2Level 3Total
Assets:
Cash equivalents:
Money market funds
$33,984 $— $— $33,984 
Total cash equivalents33,984 — — 33,984 
Investments:
U.S. Treasury securities— 246,652 — 246,652 
U.S. Non-Treasury securities— 22,741 — 22,741 
Commercial paper— 25,505 — 25,505 
Corporate debt securities— 49,527 — 49,527 
Total investments— 344,425 — 344,425 
Total assets measured at fair value$33,984 $344,425 $— $378,409 
December 31, 2022
Level 1Level 2Level 3Total
Assets:
Cash equivalents:
Money market funds
$53,208 $— $— $53,208 
Total cash equivalents53,208 — — 53,208 
Investments:
U.S. Treasury securities— 227,692 — 227,692 
U.S. Non-Treasury securities— 10,702 — 10,702 
Commercial paper— 55,433 — 55,433 
Corporate debt securities— 79,361 — 79,361 
Total investments— 373,188 — 373,188 
Total assets measured at fair value$53,208 $373,188 $— $426,396 

There were no financial liabilities measured at fair value. The Company classifies money market funds within Level 1 of the fair value hierarchy because they are valued using quoted market prices. The Company classifies its investments in U.S. Treasury securities (Treasury bills, Treasury notes, and Treasury bonds), U.S. Non-Treasury securities (government agency debt), commercial paper, and corporate debt securities as Level 2 instruments and obtains fair value from an independent pricing service, which may use quoted market prices for identical or comparable instruments or model-driven valuations using observable market data or inputs corroborated by observable market data.
The carrying amount of the Company’s accounts receivable, other receivables, prepaid expenses and other current assets, accounts payable and accrued expenses approximate fair value due to their short maturities.
The following is a summary of the Company’s cash equivalents and investments and the gross unrealized holding gains and losses (in thousands):
September 30, 2023
Amortized Cost BasisUnrealized GainsUnrealized LossesFair Value
Assets:
Cash equivalents:
Money market funds
$33,984 $— $— $33,984 
Total cash equivalents33,984 — — 33,984 
Investments:
U.S. Treasury securities247,784 (1,133)246,652 
U.S. Non-Treasury securities22,778 — (37)22,741 
Commercial paper25,527 — (22)25,505 
Corporate debt securities49,632 (114)49,527 
Total investments345,721 10 (1,306)344,425 
Total assets measured at fair value
$379,705 $10 $(1,306)$378,409 
December 31, 2022
Amortized Cost BasisUnrealized GainsUnrealized LossesFair Value
Assets:
Cash equivalents:
Money market funds
$53,208 $— $— $53,208 
Total cash equivalents53,208 — — 53,208 
Investments:
U.S. Treasury securities228,563 25 (896)227,692 
U.S. Non-Treasury securities10,699 (3)10,702 
Commercial paper55,561 (131)55,433 
Corporate debt securities79,616 (261)79,361 
Total investments374,439 40 (1,291)373,188 
Total assets measured at fair value
$427,647 $40 $(1,291)$426,396 
As of September 30, 2023 and December 31, 2022, unrealized losses on available-for-sale investments are not attributable to credit risk and are considered to be temporary. Approximately $1.0 million of the Company’s investments have been in a continuous unrealized loss position for 12 months or longer. The Company believes it is more likely than not that investments in an unrealized loss position will be held until maturity or the recovery of the cost basis of the investment. To date, the Company has not recorded any impairment charges on marketable securities related to other-than-temporary declines in market value. As of September 30, 2023, $49.6 million of available-for-sale investments had remaining maturities between one and two years. The remainder of the available-for-sale investments have a remaining maturity of one year or less. As of September 30, 2023 and December 31, 2022, the Company recorded $0.7 million and $0.6 million of accrued interest, respectively, related to its available-for-sale investments as a component of other receivables on the condensed consolidated balance sheets.